Data IPO Calendar

"Recently" Priced IPO's and Secondaries

Company	Symbol	Issue Price	Shares	Trade Date
Lycia Therapeutics Inc.	LYCA	$18.00	17.6 million	10/23

Arcus Biosciences, Inc.	RCUS	$17.50	14.3 million	10/22

Disc Medicine Inc	IRON	$75.00	6 million	10/21

Alpha Teknova, Inc.	TKNO	$5.00	8 million	10/21

City Therapeutics, Inc.	CTY	$18.00	11.1 million	10/16

Iambic Therapeutics, Inc.	IAM	$16.00	9.375 million	10/15

Crescent Energy Company	CRGY	$12.50	80 million	10/9

TRex Bio, Inc.	TRXB	$14.00	8.34 million	10/9

Retension Pharmaceuticals, Inc.	RTSN	$12.00	3.75 million	10/9

TORM plc - BLOCK	TRMD	$40.05	6.3 million	10/6

They are a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.

Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities, LifeSci Capital

They are a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies.

Jefferies, Leerink Partners, TD Cowen

Disc Medicine (NASDAQ: IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases.

Jefferies, Leerink Partners, Morgan Stanley, Cantor Fitzgerald

TD Cowen, William Blair

They are a clinical-stage biotechnology company developing the next generation of RNA interference (“RNAi”) therapeutics designed to silence the expression of disease-relevant proteins, with the aim of delivering meaningful and durable benefits for patients in need.

Goldman Sachs, Jefferies, Stifel, Oppenheimer

They are a technology and clinical-stage life sciences company pursuing a fundamental shift in the biopharmaceutical industry.

J.P. Morgan, Jefferies, BofA Securities, Citigroup

Crescent Energy Company is a U.S. independent energy company with a portfolio of assets in basins across the lower 48 states.

J.P. Morgan, KKR, Raymond James

They are a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases.

J.P. Morgan, Evercore ISI, Cantor, Stifel, Wedbush PacGrow

They are a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.

Leerink Partners, Guggenheim Securities, Oppenheimer & Co., Titan Partners